R Squared LTD Ascendis Pharma A/S Transaction History
R Squared LTD
- $181 Billion
- Q2 2025
A detailed history of R Squared LTD transactions in Ascendis Pharma A/S stock. As of the latest transaction made, R Squared LTD holds 1,212 shares of ASND stock, worth $232,085. This represents 0.12% of its overall portfolio holdings.
Number of Shares
1,212Holding current value
$232,085% of portfolio
0.12%Shares
1 transactions
Others Institutions Holding ASND
# of Institutions
279Shares Held
61.8MCall Options Held
151KPut Options Held
226K-
Ra Capital Management, L.P. Boston, MA10.3MShares$1.97 Billion33.28% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.05 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.22MShares$999 Million13.16% of portfolio
-
Janus Henderson Group PLC London, X04.49MShares$859 Million0.4% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$815 Million1.14% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $10.7B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...